CAG
AGN

Crestwood Advisors Group’s Allergan plc AGN Stock Holding History

Crestwood Advisors Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-388
Closed -$95K – 478
2017
Q1 		$95K Buy
+388
New +$90.4K 0.01% 200
2016
Q2 		– Sell
-788
Closed -$211K – 145
2016
Q1 		$211K Buy
788
+15
+2% +$4.29K 0.02% 129
2015
Q4 		$242K Buy
+773
New +$230K 0.03% 134
2015
Q2 		– Sell
-1,106
Closed -$329K – 166
2015
Q1 		$329K Buy
+1,106
New +$315K 0.05% 101

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Crestwood Advisors Group's AGN Position: Q2 2017 in Review

Crestwood Advisors Group sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 388 shares — an estimated $95K sold.

Crestwood Advisors Group first reported a position in AGN in Q1 2015 and held it in 4 quarters. The position peaked at $329K in Q1 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Crestwood Advisors Group reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Crestwood Advisors Group sold 388 Allergan plc shares in Q2 2017, an estimated $95K.
  • Crestwood Advisors Group first reported a position in Allergan plc in Q1 2015 and held it in 4 quarters.
  • Crestwood Advisors Group's Allergan plc position peaked at $329K in Q1 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Crestwood Advisors Group's 13F filing for Q2 2017, filed 31 Jul 2017.